Home » Topics » BioWorld Science

BioWorld Science
RSS

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Botulinum toxin type A: Treatment of choice for idiopathic cervical dystonia

June 7, 1996

Connective Therapeutics' peptide vaccine trial results presented

June 7, 1996

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Cytokine polypeptides described by Immunex

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Trials expected to begin on CoCensys' CCD-1042

June 7, 1996

Genzyme Transgenics and Boehringer Mannheim reach agreement

June 7, 1996

Neoprobe and Dow enter licensing agreement

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...